Subject: PZOOD Hits Major Milestone and Enters the Revenue Cycle for the First Time

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
PZOOD Hits Major Milestone and Enters the Revenue Cycle for the First Time
Hot Stock to WatchHot Stock to Watch

Company: Pazoo, Inc. (Pink Sheets: PZOOD)


Last:

Price: 0.009

Change (%): + 0.0014 (18.42)

Volume: 659,753
PZOO Chart

Pazoo, Inc. Subsidiary MA and Associates, LLC Bring in First Revenue

FLORHAM PARK, N.J., May 16, 2017 /PRNewswire/ - Pazoo, Inc. (OTC Pinks: PZOO) is pleased to announce that its subsidiary, MA & Associates, LLC (MA), a State of Nevada licensed marijuana testing laboratory in Las Vegas, has recorded its first transaction resulting in billing its first revenues.

Over the last several weeks, MA ran simulated tests to process samples in order to fine tune all aspects of its laboratory operations including order processing and laboratory methods so that lab and client service would be best-in-class for the entire State of Nevada. The senior staff wanted to achieve this benchmark so that potential MA clients would be confident and extremely satisfied with MA’s laboratory and account services, as well as the accurate and reliable test results that will follow from the state-of-the art technology and precise methodology used. With the achievement of the aforementioned benchmark, MA took the next step and went from simulated sample testing to testing samples from the licensed marketplace which has resulted in MA’s first revenue. The lab employees are very excited to now be servicing the growing medical marijuana marketplace in Nevada and being part of this new industry’s safeguards for the medical marijuana patients and the medical marijuana community of Nevada, in general.

CEO of Pazoo, David Cunic, stated, “Everyone at Pazoo as well as MA is extremely excited about the lab bringing in revenues. This has been a long time coming, and to see it finally become a reality is amazing. We wanted to ensure lab operations and account services were done the proper way before taking in revenue. With that being said, we want to thank the shareholders, the investors, and our customers for their patience as they were all very eager to have us open. We look forward to reconnecting with the many operators who asked to work with us as new customers, turning our LOI’s into paying customers, and servicing the State of Nevada with our much needed testing services”

Continue Reading

Like Us on FacebookFollow Us on Twitter

IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks